Recall: D-0559-2024

Class II - Potentially Harmful

Class IIClassification

2024-05-30Initiated

TerminatedStatus

Lupin Pharmaceuticals Inc.Firm

Product

Cefixime for Oral Suspension USP 200 mg/5 mL (50 mL Pack size), Powder for oral suspension, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore Maryland, Manufactured by: Lupin Limited, Mandideep, India NDC 68180-407-03

Reason

Failed Content Uniformity Specifications

Distribution

Nationwide in the US

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.